Current Management of Infantile Hemangiomas

Seminars in Cutaneous Medicine and Surgery

Volumn 29, Issue 2, 2010, Pages 106-114

  Maguiness, Sheilagh M ^a   Frieden, Ilona J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BECAPLERMIN; CLOBETASOL; CORTICOSTEROID; COTRIMOXAZOLE; HYDROGEN PEROXIDE; IMIQUIMOD; METHYLPREDNISOLONE; METRONIDAZOLE; PETROLATUM; PREDNISOLONE; PREDNISONE; PROPRANOLOL; RANITIDINE; RECOMBINANT ALPHA2A INTERFERON; RECOMBINANT ALPHA2B INTERFERON; TIMOLOL; TRIAMCINOLONE; VINCRISTINE; XIPAMIDE;

AGE DISTRIBUTION; AIRWAY HEMANGIOMA; ANTICIPATORY GUIDANCE; BRADYCARDIA; CLINICAL TRIAL; DEFORMITY; DISEASE ASSOCIATION; DISEASE COURSE; ESTHETICS; EVIDENCE BASED MEDICINE; FACE TUMOR; FOLLOW UP; FUNCTIONAL DISEASE; HEMANGIOMA; HUMAN; HYDROCOLLOID DRESSING; HYPOGLYCEMIA; INFANTILE HEMANGIOMA; LARYNGOSCOPY; LASER; LIVER HEMANGIOMA; LUMBOSACRAL HEMANGIOMA; LUMBOSACRAL SPINE; NEODYMIUM LASER; NOSE APEX; NOSE MALFORMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT; PERIORBITAL HEMANGIOMA; PHACES SYNDROME; PULSED DYE LASER; REVIEW; RISK FACTOR; SCAR FORMATION; SEGMENTAL EXTREMITY HEMANGIOMA; SKIN PAIN; SKIN ULCER; SPINAL DYSRAPHISM; STEROID THERAPY; TUMOR GROWTH; TUMOR LOCALIZATION; VISUAL IMPAIRMENT; WOUND HEALING;

FACIAL NEOPLASMS; GLUCOCORTICOIDS; HEMANGIOMA; HUMANS; INFANT; LASER THERAPY; LIVER NEOPLASMS; PREDNISOLONE; PREDNISONE; SKIN NEOPLASMS; SKIN ULCER;

EID: 77953315481     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2010.03.009     Document Type: Review

References (68)

1. Kilcline C., and Frieden I.J. Infantile hemangiomas: How common are they?. A systematic review of the medical literature. Pediatr Dermatol 25 (2008) 168-173
2. Grantzow R., Schmittenbecher P., Cremer H., et al. Hemangiomas in infancy and childhood. S 2k guideline of the German Society of Dermatology with the working group pediatric dermatology together with the German Society for Pediatric Surgery and the German Society for Pediatric Medicine. J Dtsch Dermatol Ges 6 (2008) 324-329
3. Schachner L., and Hansen R. Pediatric Dermatology (2003), Elsevier, New York
4. Chang L.C., Haggstrom A.N., Drolet B.A., et al. Growth characteristics of infantile hemangiomas: Implications for management. Pediatrics 122 (2008) 360-367
5. Corella F., Garcia-Navarro X., Ribe A., et al. Abortive or minimal-growth hemangiomas: Immunohistochemical evidence that they represent true infantile hemangiomas. J Am Acad Dermatol 58 (2008) 685-690
6. Brandling-Bennett H.A., Metry D.W., Baselga E., et al. Infantile hemangiomas with unusually prolonged growth phase: A case series. Arch Dermatol 144 (2008) 1632-1637
7. Chamlin S.L., Haggstrom A.N., Drolet B.A., et al. Multicenter prospective study of ulcerated hemangiomas. J Pediatr 151 (2007) 684-689 689.e1
8. Sterker I., and Gräfe G. Periocular hemangiomas in childhood-Functional and esthetic results. Strabismus 12 (2004) 103-110
9. Cruz O.A., Zarnegar S.R., and Myers S.E. Treatment of periocular capillary hemangioma with topical clobetasol propionate. Ophthalmology 102 (1995) 2012-2015
10. Aldave A.J., Shields C.L., and Shields J.A. Surgical excision of selected amblyogenic periorbital capillary hemangiomas. Ophthal Surg Lasers 30 (1999) 754-757
11. Lode H., Deeg K., and Krauss J. Spinal sonography in infants with cutaneous birth markers in the lumbo-sacral region-An important sign of occult spinal dysrhaphism and tethered cord. Ultraschall Med 29 suppl 5 (2008) 281-288
12. Shian W.J., Chi C.S., and Wong T.T. Lipomyelomeningocele: A 9-year review. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 35 (1994) 57-62
13. Stockman A., Boralevi F., Taïeb A., et al. SACRAL syndrome: Spinal dysraphism, anogenital, cutaneous, renal and urologic anomalies, associated with an angioma of lumbosacral localization. Dermatol Basel 214 (2007) 40-45
14. Girard C., Bigorre M., Guillot B., et al. PELVIS syndrome. Arch Dermatol 142 (2006) 884-888
15. Mulliken J.B., Marler J.J., Burrows P.E., et al. Reticular infantile hemangioma of the limb can be associated with ventral-caudal anomalies, refractory ulceration, and cardiac overload. Pediatr Dermatol 24 (2007) 356-362
16. Haggstrom A.N., Drolet B.A., Baselga E., et al. Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment. Pediatrics 118 (2006) 882-887
17. Mulliken J.B., Rogers G.F., and Marler J.J. Circular excision of hemangioma and purse-string closure: The smallest possible scar. Plast Reconstr Surg 109 (2002) 1544-1554 discussion: 1555
18. Faguer K., Dompmartin A., Labbé D., et al. Early surgical treatment of Cyrano-nose haemangiomas with Rethi incision. Br J Plast Surg 55 (2002) 498-503
19. Metry D., Heyer G., Hess C., et al. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 124 (2009) 1447-1456
20. Haggstrom A.N., Lammer E.J., Schneider R.A., et al. Patterns of infantile hemangiomas: New clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 117 (2006) 698-703
21. Metry D.W., Garzon M.C., Drolet B.A., et al. PHACE syndrome: Current knowledge, future directions. Pediatr Dermatol 26 (2009) 381-398
22. Pransky S.M., and Canto C. Management of subglottic hemangioma. Curr Opin Otolaryngol Head Neck Surg 12 (2004) 509-512
23. Saetti R., Silvestrini M., Cutrone C., et al. Treatment of congenital subglottic hemangiomas: Our experience compared with reports in the literature. Arch Otolaryngol Head Neck Surg 134 (2008) 848-851
24. Buckmiller L., Dyamenahalli U., and Richter G.T. Propranolol for airway hemangiomas: Case report of novel treatment. Laryngoscope 119 (2009) 2051-2054
25. Maturo S., and Hartnick C. Initial experience using propranolol as the sole treatment for infantile airway hemangiomas. Int J Pediatr Otorhinolaryngol (2010). http://www.ncbi.nlm.nih.gov.login.ezproxy.library.ualberta.ca/pubmed/20071038 Accessed February 5, 2010
26. Christison-Lagay E.R., Burrows P.E., Alomari A., et al. Hepatic hemangiomas: Subtype classification and development of a clinical practice algorithm and registry. J Pediatr Surg 42 (2007) 62-67 discussion: 67-68
27. Kassarjian A., Zurakowski D., Dubois J., et al. Infantile hepatic hemangiomas: Clinical and imaging findings and their correlation with therapy. AJR Am J Roentgenol 182 (2004) 785-795
28. Kassarjian A., Dubois J., and Burrows P.E. Angiographic classification of hepatic hemangiomas in infants. Radiology 222 (2002) 693-698
29. Iyer C.P., Stanley P., and Mahour G.H. Hepatic hemangiomas in infants and children: A review of 30 cases. Am Surg 62 (1996) 356-360
30. Bessho K., Etani Y., Ichimori H., et al. Increased type 3 iodothyronine deiodinase activity in a regrown hepatic hemangioma with consumptive hypothyroidism. Eur J Pediatr 169 (2010) 215-221
31. Jacobs A.H. Strawberry hemangiomas; the natural history of the untreated lesion. Calif Med 86 (1957) 8-10
32. Tanner J.L., Dechert M.P., and Frieden I.J. Growing up with a facial hemangioma: Parent and child coping and adaptation. Pediatrics 101 (1998) 446-452
33. Minzer-Conzetti K., Garzon M.C., Haggstrom A.N., et al. Information about infantile hemangiomas on the internet: How accurate is it?. J Am Acad Dermatol 57 (2007) 998-1004
34. Sugarman J.L., Mauro T.M., and Frieden I.J. Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor. Arch Dermatol 138 (2002) 314-316
35. Metz B.J., Rubenstein M.C., Levy M.L., et al. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol 140 (2004) 867-870
36. Frieden I.J. Addendum: Commentary on becaplermin gel (Regranex) for hemangiomas. Pediatr Dermatol 25 (2008) 590
37. David L.R., Malek M.M., and Argenta L.C. Efficacy of pulse dye laser therapy for the treatment of ulcerated haemangiomas: A review of 78 patients. Br J Plast Surg 56 (2003) 317-327
38. Yan A.C. Pain management for ulcerated hemangiomas. Pediatr Dermatol 25 (2008) 586-589
39. Michel J., and Patural H. Response to oral propranolol therapy for ulcerated hemangiomas in infancy. Arch Pediatr 16 (2009) 1565-1568
40. Garzon M.C., Lucky A.W., Hawrot A., et al. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acad Dermatol 52 (2005) 281-286
41. Ranchod T.M., Frieden I.J., and Fredrick D.R. Corticosteroid treatment of periorbital haemangioma of infancy: A review of the evidence. Br J Ophthalmol 89 (2005) 1134-1138
42. McCuaig C.C., Dubois J., Powell J., et al. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol 26 (2009) 203-212
43. Barry R.B.M., Hughes B.R., and Cook L.J. Involution of infantile haemangiomas after imiquimod 5% cream. Clin Exp Dermatol 33 (2008) 446-449
44. Ho N.T.C., Lansang P., and Pope E. Topical imiquimod in the treatment of infantile hemangiomas: A retrospective study. J Am Acad Dermatol 56 (2007) 63-68
45. Brown B.Z., and Huffaker G. Local injection of steroids for juvenile hemangiomas which disturb the visual axis. Ophthal Surg 13 (1982) 630-633
46. Egbert J.E., Schwartz G.S., and Walsh A.W. Diagnosis and treatment of an ophthalmic artery occlusion during an intralesional injection of corticosteroid into an eyelid capillary hemangioma. Am J Ophthalmol 121 (1996) 638-642
47. Buckmiller L.M., Francis C.L., and Glade R.S. Intralesional steroid injection for proliferative parotid hemangiomas. Int J Pediatr Otorhinolaryngol 72 (2008) 81-87
48. Cohen S.R., and Wang C.I. Steroid treatment of hemangioma of the head and neck in children. Ann Otol Rhinol Laryngol 81 (1972) 584-590
49. Rössler J., Wehl G., and Niemeyer C.M. Evaluating systemic prednisone therapy for proliferating haemangioma in infancy. Eur J Pediatr 167 (2008) 813-815
50. Pope E., Krafchik B.R., Macarthur C., et al. Oral versus high-dose pulse corticosteroids for problematic infantile hemangiomas: A randomized, controlled trial. Pediatrics 119 (2007) e1239-e1247
51. Bennett M.L., Fleischer A.B., Chamlin S.L., et al. Oral corticosteroid use is effective for cutaneous hemangiomas: An evidence-based evaluation. Arch Dermatol 137 (2001) 1208-1213
52. Lomenick J.P., Reifschneider K.L., Lucky A.W., et al. Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas. Arch Dermatol 145 (2009) 262-266
53. Boon L.M., MacDonald D.M., and Mulliken J.B. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg 104 (1999) 1616-1623
54. Aviles R., Boyce T.G., and Thompson D.M. Pneumocystis carinii pneumonia in a 3-month-old infant receiving high-dose corticosteroid therapy for airway hemangiomas. Mayo Clin Proc 79 (2004) 243-245
55. Maronn M.L., Corden T., and Drolet B.A. Pneumocystis carinii pneumonia in infant treated with oral steroids for hemangioma. Arch Dermatol 143 (2007) 1224-1225
56. Léauté-Labrèze C., Dumas de la Roque E., Hubiche T., et al. Propranolol for severe hemangiomas of infancy. N Engl J Med 358 (2008) 2649-2651
57. Marsciani A., Pericoli R., Alaggio R., et al. Massive response of severe infantile hepatic hemangioma to propanolol. Pediatr Blood Cancer 54 (2010) 176
58. Taban M., and Goldberg R.A. Propranolol for orbital hemangioma. Ophthalmology 117 (2010) 195-195:e4
59. Léauté-Labrèze C., and Taïeb A. Efficacy of beta-blockers in infantile capillary haemangiomas: the physiopathological significance and therapeutic consequences. Ann Dermatol Venereol 135 (2008) 860-862
60. Frieden I.J., and Drolet B.A. Propranolol for infantile hemangiomas: Promise, peril, pathogenesis. Pediatr Dermatol 26 (2009) 642-644
61. Siegfried E.C., Keenan W.J., and Al-Jureidini S. More on propranolol for hemangiomas of infancy. N Engl J Med 359 (2008) 2846 author reply: 2846-2847
62. Barlow C.F., Priebe C.J., Mulliken J.B., et al. Spastic diplegia as a complication of interferon alfa-2a treatment of hemangiomas of infancy. J Pediatr 132 (1998) 527-530
63. Hoyoux C. Vincristine treatment for management of alarming hemangiomas in infancy [in French]. Rev Med Liege 63 (2008) 14-17
64. Fawcett S.L., Grant I., Hall P.N., et al. Vincristine as a treatment for a large haemangioma threatening vital functions. Br J Plast Surg 57 (2004) 168-171
65. Witman P.M., Wagner A.M., Scherer K., et al. Complications following pulsed dye laser treatment of superficial hemangiomas. Lasers Surg Med 38 (2006) 116-123
66. Rizzo C., Brightman L., Chapas A.M., et al. Outcomes of childhood hemangiomas treated with the pulsed-dye laser with dynamic cooling: A retrospective chart analysis. Dermatol Surg 35 (2009) 1947-1954
67. Werner J.A., Lippert B.M., Godbersen G.S., et al. Treatment of hemangioma with the neodymium: yttrium-aluminum-garnet laser (Nd: YAG laser). [in German]. Laryngo Rhino Otologie 71 (1992) 388-395
68. Achauer B.M., Chang C.J., Vanderkam V.M., et al. Intralesional photocoagulation of periorbital hemangiomas. Plast Reconstr Surg 103 (1999) 11-16 discussion: 17-19